Facilities & Capacity

Advanced Production Infrastructure for Diverse Formats & Biomaterials

Precision production capability built on diverse biomaterials and state-of-the-art smart equipment

We operate a customized production infrastructure that fully realizes a wide range of polymer and bio raw materials — HA, PN, CaHA, PLA/PDLLA, rH COL III (collagen), exosomes, and various novel materials. With dedicated smart equipment and aseptic filling systems optimized for each format — syringe, vial, and lyophilized — we guarantee a large-scale, stable supply of over 24 million units per year.

Production Lines

Syringe Production Line

Syringe Production Line

  • Annual CAPA: 12 million units per year (1 mL basis)
  • Target Formats: HA, PN, CaHA, HA Hybrid
  • Key Features: Precision filling technology for high-viscosity elastic materials and an autoclave sterilization system to maintain complete asepsis
Vial Production Line

Vial Production Line

  • Annual CAPA: 11 million units per year (5 mL basis)
  • Target Formats: PN, Exosome, Collagen, NAD+
  • Key Features: A fully integrated automated line — washing, tunnel sterilization, filling, lyophilization, and cap sealing — ensures high-quality, repeatable productivity
Lyophilization Production Line

Lyophilization Production Line

  • Annual CAPA: 1.2 million units per year (PDLLA 200 mg basis)
  • Target Formats: PLA fillers and skin boosters
  • Key Features: Particle homogenization via membrane emulsification, particle lyophilization, precision count filling, and linked EO gas sterilization

Packaging System

High-Speed Automated Packaging

A precision automation system linked from labeling through PTP blister forming, sealing, cartoning, and wrapping secures consistency and high productivity in mass production.

Flexible Manual Packaging

A dedicated manual packaging system runs in parallel to respond quickly to small-batch, multi-product orders and partner-specific packaging specifications.

Reanzen Product Inquiry.

Explore Reanzen's full product lineup